S15 Ep43: Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer
OncLive® On Air
00:00
Using ADC+ICI now: real‑world considerations
Heather McArthur and colleagues discuss when they offer ADC+ICI combinations, access, and compassionate‑use examples.
Play episode from 20:48
Transcript
